Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D X Jin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]|October 1, 1994
[Nutritional survey]D X Jin
European Review for Medical and Pharmacological Sciences|July 24, 2013
Could torasemide be a prophylactic agent of contrast induced acute kidney injury? A review about this fieldX-M Li, D-X Jin, H-L Cong
BMC Musculoskeletal Disorders|July 22, 2010
Reverse LISS plating for intertrochanteric hip fractures in elderly patientsC Q Zhang, Y Sun, D X Jin, et al.
Lupus|September 19, 2009
Treatment of femoral head osteonecrosis in patients with systemic lupus erythematosus by free vascularised fibular graftingY Sun, C Q Zhang, S B Chen, et al.
The Journal of Bone and Joint Surgery. British Volume|October 5, 2011
Free vascularised fibular graft for post-traumatic osteonecrosis of the femoral head in teenage patientsC Q Zhang, Y Sun, S B Chen, et al.
Transplantation Proceedings|November 18, 2009
Curative effect and safety of vascularized fibula grafting in renal transplant recipients with osteonecrosis of the femoral head: three case reportsY J Guo, D X Jin, C Q Zhang, et al.
NPJ Precision Oncology|July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.
NPJ Precision Oncology|September 18, 2021
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2018
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerE S Sokol, Y X Feng, D X Jin, et al.
ESMO Open|November 3, 2023
Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO studyC B Westphalen, J Federer-Gsponer, C Pauli, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]|October 1, 1994
[Nutritional survey]D X Jin
European Review for Medical and Pharmacological Sciences|July 24, 2013
Could torasemide be a prophylactic agent of contrast induced acute kidney injury? A review about this fieldX-M Li, D-X Jin, H-L Cong
BMC Musculoskeletal Disorders|July 22, 2010
Reverse LISS plating for intertrochanteric hip fractures in elderly patientsC Q Zhang, Y Sun, D X Jin, et al.
Lupus|September 19, 2009
Treatment of femoral head osteonecrosis in patients with systemic lupus erythematosus by free vascularised fibular graftingY Sun, C Q Zhang, S B Chen, et al.
The Journal of Bone and Joint Surgery. British Volume|October 5, 2011
Free vascularised fibular graft for post-traumatic osteonecrosis of the femoral head in teenage patientsC Q Zhang, Y Sun, S B Chen, et al.
Transplantation Proceedings|November 18, 2009
Curative effect and safety of vascularized fibula grafting in renal transplant recipients with osteonecrosis of the femoral head: three case reportsY J Guo, D X Jin, C Q Zhang, et al.
NPJ Precision Oncology|July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.
NPJ Precision Oncology|September 18, 2021
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2018
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerE S Sokol, Y X Feng, D X Jin, et al.
ESMO Open|November 3, 2023
Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO studyC B Westphalen, J Federer-Gsponer, C Pauli, et al.
Pageof 2